Sunday November 8 2009 | Biotechnology feed | All feeds

«PDL BioPharma

Below is an extended PDL BioPharma patents listing. Click here to return to the PDL BioPharma main Biocorporate entry.

PDL BioPharma Patents :
US Patent No.	Title
7435589	Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
7183390	Humanized antibodies to gamma-interferon
7189507	Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
7217797	Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis
7217798	Alteration of Fc-fusion protein serum half-lives by mutagenesis
7223393	Amphiregulin antibodies and their use to treat cancer and psoriasis
7276372	Antibodies against GPR64 and uses thereof
7276589	Chimeric and humanized antibodies to .alpha.5.beta.1 integrin that modulate angiogenesis
7285268	Chimeric and humanized antibodies to .alpha.5.beta.1 integrin that modulate angiogenesis
7288248	Antibodies against cancer antigen TMEFF2 and uses thereof
7361740	Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis
7365168	Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis
7381803	Humanized antibodies against CD3
7399469	Anti-LFL2 antibodies for the diagnosis, prognosis and treatment of cancer
7122185	Anti-CCR5 antibody

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.